13F HOLDINGS REPORT
BML Capital Management, LLC
Quarter ended Q3 2023 · Filed July 24, 2023 · Accession 0001754960-23-000204
Total Value
$111.2M
Positions
31
Other Managers
0
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78468R663 | 200,000 | $18.4M | 16.52% |
| 2 | ISHARES TR | 46436E718 | 180,000 | $18.1M | 16.29% |
| 3 | CYTEIR THERAPEUTICS INC | 23284P103 | 3,250,000 | $8.4M | 7.60% |
| 4 | ATEA PHARMACEUTICALS INC | AVIR | 2,236,239 | $8.4M | 7.52% |
| 5 | ADVERUM BIOTECHNOLOGIES INC | 00773U108 | 5,157,179 | $8.2M | 7.38% |
| 6 | PARDES BIOSCIENCES INC | 69945Q105 | 3,791,633 | $6.9M | 6.17% |
| 7 | TALARIS THERAPEUTICS INC | 87410C104 | 2,000,000 | $6.1M | 5.47% |
| 8 | ATHIRA PHARMA INC | 04746L104 | 1,864,907 | $5.5M | 4.95% |
| 9 | ELIEM THERAPEUTICS INC | CLYM | 1,583,170 | $4.4M | 3.99% |
| 10 | ABERCROMBIE & FITCH CO | ANF | 117,500 | $4.4M | 3.98% |
| 11 | ASTROTECH CORP | ASTC | 220,410 | $3.1M | 2.81% |
| 12 | ORAMED PHARMACEUTICALS INC | ORMP | 850,000 | $3.0M | 2.74% |
| 13 | QUINCE THERAPEUTICS INC | QNCX | 1,411,839 | $2.1M | 1.91% |
| 14 | PASSAGE BIO INC | PASG | 2,058,767 | $1.9M | 1.74% |
| 15 | FORTE BIOSCIENCES INC | FBRX | 1,735,075 | $1.8M | 1.62% |
| 16 | ENLIVEN THERAPEUTICS INC | ELVN | 74,232 | $1.5M | 1.36% |
| 17 | ARCA BIOPHARMA INC | 00211Y506 | 706,930 | $1.4M | 1.29% |
| 18 | TILLYS INC | 886885102 | 190,518 | $1.3M | 1.20% |
| 19 | LISATA THERAPEUTICS INC | LSTA | 243,839 | $902,204 | 0.81% |
| 20 | VERRICA PHARMACEUTICALS INC | VRCA | 150,000 | $865,500 | 0.78% |
| 21 | SURROZEN INC | SRZNW | 1,459,084 | $802,496 | 0.72% |
| 22 | MILESTONE PHARMACEUTICALS IN | MIST | 272,500 | $776,625 | 0.70% |
| 23 | RETRACTABLE TECHNOLOGIES INC | RVP | 668,575 | $768,861 | 0.69% |
| 24 | NEXTCURE INC | NXTC | 306,465 | $551,637 | 0.50% |
| 25 | GRAPHITE BIO INC | 38870X104 | 152,291 | $395,957 | 0.36% |
| 26 | CALCIMEDICA INC | CALC | 88,781 | $356,012 | 0.32% |
| 27 | AVROBIO INC | 05455M100 | 256,277 | $243,489 | 0.22% |
| 28 | MEI PHARMA INC | LITS | 22,966 | $151,116 | 0.14% |
| 29 | INVIVYD INC | IVVD | 134,696 | $141,431 | 0.13% |
| 30 | RAIN ONCOLOGY INC | 75082Q105 | 72,926 | $87,511 | 0.08% |
| 31 | NEOLEUKIN THERAPEUTICS INC | 64049K104 | 23,749 | $19,712 | 0.02% |